Mr. Tope Adeniyi
CEO
AXA Mansard Health
AXA Mansard Health’s International Healthcare Plan, iMED, offers Nigerians access to comprehensive medical coverage for cancer, as well as critical medical procedures such as organ and bone marrow transplants, and international emergency medical assistance at leading healthcare facilities in Nigeria, the United States, the United Kingdom and Dubai.
According to estimates by the Global Cancer Observatory (GLOBOCAN), more than 150,000 new cancer cases are diagnosed annually in Nigeria, with over 90,000 deaths recorded each year. Among men, prostate, colorectal and liver cancers remain the most commonly diagnosed, while breast, cervical and colorectal cancers account for the highest incidence among women.
In response to these evolving healthcare needs, AXA Mansard was designed to provide its eligible enrolees with access to premium international health insurance coverage that supports access to advanced medical care for eligible medical conditions through a network of accredited healthcare local and international providers. This product offers comprehensive cover for a broad range of medical services, including chronic condition management, chemotherapy and radiotherapy where medically necessary, helping individuals prepare for unexpected health events and associated medical expenses.
Speaking on the rationale behind the introduction of the plan, Chief Executive Officer, AXA Mansard Health, Tope Adeniyi, said the company remains committed to developing solutions that address evolving healthcare needs while reducing barriers to specialized treatment.
“It’s heartbreaking to see the growing impact cancer continues to have on families and communities, not only in Nigeria but across the world. As a company committed to acting for human progress by protecting what matters, we recognise the need to continually develop healthcare solutions that respond to the realities our customers face.”
“Through iMED, we are bringing world-class healthcare closer to Nigerians by providing access to specialised treatment options across local and international medical facilities. This solution helps bridge critical gaps in healthcare access and gives our customers greater confidence that they can receive quality care when they need it most, regardless of where they are in the world,” Adeniyi said.
With access to an extensive network of leading healthcare providers across key medical destinations, including the United States, the United Kingdom and Dubai, iMED is designed to provide individuals, families and corporate clients with enhanced protection against the financial and emotional burden often associated with serious illnesses.
Beyond cancer care, the plan also provides access to treatment for a range of chronic and complex medical conditions, reinforcing AXA Mansard Health’s commitment to improving health outcomes and ensuring Nigerians have access to quality healthcare without geographical limitations.
As healthcare needs continue to evolve and demand for specialised treatments also increases, AXA Mansard Health remains focused on delivering innovative solutions that empower customers to navigate complex medical journeys with greater peace of mind while supporting broader efforts to improve health and well-being across Nigeria.
